Serum proteome-lipidome integration reveals a mitochondrial-lipid remodeling axis in MASH-associated fibrosis

Background Metabolic dysfunction-associated steatohepatitis (MASH) is a progressive form of steatotic liver disease in which fibrosis is the principal determinant of adverse clinical outcomes. However, the circulating molecular architecture that links metabolic injury to fibrotic remodeling remains incompletely defined. Methods Untargeted UHPLC-MS/MS lipidomics was performed in a biopsy-characterized cohort of 60 individuals (30 with MASH-associated fibrosis and 30 with non-alcoholic fatty liver NAFL). Serum data-independent acquisition proteomics was performed in a randomly selected, balanced 20-participant sub-cohort (10 MASH and 10 NAFL), and this sub-cohort was used for the integrated multi-omics analyses. Results This analysis identified extensive molecular remodeling in MASH, comprising 422 differentially expressed proteins and 240 altered lipid species. Proteomic enrichment highlighted broad suppression of oxidative phosphorylation, fatty acid degradation, and tricarboxylic acid cycle pathways, together with activation of extracellular matrix-receptor interaction and focal adhesion pathways. Lipidomic profiling revealed predominant remodeling of glycerophospholipids, including marked alterations in phosphatidylcholines, phosphatidylethanolamines, and cardiolipins. Network analysis identified a fibrosis-associated protein module centered on SMPD1, PSMB5, GPD1, and IFI16, whereas cross-omics integration linked LPCAT3 to phosphatidylcholine remodeling and NR1I3 to triglyceride-associated variation. External transcriptomic validation across independent GEO cohorts supported concordant expression patterns for key signatures, including SMPD1, LPCAT3, CD177, and TMOD1. Conclusions MASH-associated fibrosis was associated with a coordinated serum proteome-lipidome state characterized by omics signatures consistent with altered mitochondrial energy metabolism, glycerophospholipid remodeling, and extracellular matrix activation, and nominate candidate molecular signatures for future mechanistic and biomarker studies.

Authors

Institutions

Publication Details

Journal
Journal of Translational Medicine
Published
2026-11-20
DOI
https://doi.org/10.1186/s12967-026-09177-9
Primary Topic
Liver Disease Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Serum proteome-lipidome integration reveals a mitochondrial-lipid remodeling axis in MASH-associated fibrosis

Sheng Gao, Manying Zhang, JiaEn Yang, Weili Li et al.
5 links
Journal of Translational Medicine
Liver Disease Diagnosis and Treatment
article

Serum proteome-lipidome integration reveals a mitochondrial-lipid remodeling axis in MASH-associated fibrosis

Sheng Gao, Manying Zhang, JiaEn Yang, Weili Li, Shaodong Chen, Qianguo Mao, Xinyi Kwan, Yaoyu Liu, Chuncheng Wu, Xiaoting Zheng, Yong Wang, Siyan Chen, Huiqing Liang, Yue Chen
article en

Abstract

Background Metabolic dysfunction-associated steatohepatitis (MASH) is a progressive form of steatotic liver disease in which fibrosis is the principal determinant of adverse clinical outcomes. However, the circulating molecular architecture that links metabolic injury to fibrotic remodeling remains incompletely defined. Methods Untargeted UHPLC-MS/MS lipidomics was performed in a biopsy-characterized cohort of 60 individuals (30 with MASH-associated fibrosis and 30 with non-alcoholic fatty liver NAFL). Serum data-independent acquisition proteomics was performed in a randomly selected, balanced 20-participant sub-cohort (10 MASH and 10 NAFL), and this sub-cohort was used for the integrated multi-omics analyses. Results This analysis identified extensive molecular remodeling in MASH, comprising 422 differentially expressed proteins and 240 altered lipid species. Proteomic enrichment highlighted broad suppression of oxidative phosphorylation, fatty acid degradation, and tricarboxylic acid cycle pathways, together with activation of extracellular matrix-receptor interaction and focal adhesion pathways. Lipidomic profiling revealed predominant remodeling of glycerophospholipids, including marked alterations in phosphatidylcholines, phosphatidylethanolamines, and cardiolipins. Network analysis identified a fibrosis-associated protein module centered on SMPD1, PSMB5, GPD1, and IFI16, whereas cross-omics integration linked LPCAT3 to phosphatidylcholine remodeling and NR1I3 to triglyceride-associated variation. External transcriptomic validation across independent GEO cohorts supported concordant expression patterns for key signatures, including SMPD1, LPCAT3, CD177, and TMOD1. Conclusions MASH-associated fibrosis was associated with a coordinated serum proteome-lipidome state characterized by omics signatures consistent with altered mitochondrial energy metabolism, glycerophospholipid remodeling, and extracellular matrix activation, and nominate candidate molecular signatures for future mechanistic and biomarker studies.

Journal of Translational Medicine
Guangzhou University of Chinese Medicine (CN), Fujian University of Traditional Chinese Medicine (CN), Beijing University of Chinese Medicine (CN), Xiamen University (CN), Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine (CN)
National Natural Science Foundation of China, Natural Science Foundation of Fujian Province
Good health and well-being
Liver Disease Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon